Portola制药(PTLA)

淘沙见金2017-11-07 09:54

$Portola制药(PTLA)$ Bevyxxa 终于快上市了。On this point the FDA has informed us that these reports may require additional time for review. As a result the action dates for the formal decision on the prior approval supplement or what is known as the PAS may still occur on Nove...查看全文

淘沙见金2017-10-08 11:58

$Portola制药(PTLA)$ The bleeding risk with Xarelto is already well known. In fact, Bayer and J&J are facing more than 18,000 lawsuits over the side effect in state and federal courts. So far, the companies have had the upper hand in the litigation: In August, a jury in a ...查看全文

PTLA投资分析报告

Replix锐璞美股2017-09-26 17:29

$Portola制药(PTLA)$
作者：飞冲天 *本文由作者独家授权Replix锐璞生物医药研究发布
投资摘要：
1. Portola公司的抗凝血剂新药Betrixaban（贝曲沙班胶囊）已经通过FDA审批，目前正处在量产准备阶段，预计将于今年年底开卖，成为继利伐沙班、阿哌沙班、依度沙班之后的第4个直接Xa因子...查看全文

淘沙见金2017-09-06 01:29

$Portola制药(PTLA)$ Portola Pharmaceuticals to Host Webcast and Conference Call Today, Tuesday, Sept. 5 to Provide Further Details on Bevyxxa® (betrixaban) Launch. 从市场的反应来看管理层又要出幺蛾子么？难道又要宣布上市时间被进一步推迟？查看全文

pharma-yang2017-08-18 23:24

$Portola制药(PTLA)$ 这股基本面很好，一个批件在手，一个产品上市申请在审，按理不应跌跌不休，可最近的下跌趋势线太明显了查看全文

飞冲天2017-08-11 10:18

$Portola制药(PTLA)$ Portola Pharmaceuticals Still Has Significant Potential After Recent Surge
网页链接
虽然管理层能力有点差，但风险小了很多，可以关注查看全文

淘沙见金2017-08-11 08:31

$Portola制药(PTLA)$ Re-submission of the AndeXxa BLA is the key. Class 1 -Total 2 months. Beginning of September classification, Beginning of October decision.
Class 2 - Total 6 months. Beginning of September classification, Beginning of February decision. Received a resp...查看全文

波澜壮阔因为有爱2017-08-10 05:24

Portola Pharmaceuticals misses by $0.24, misses on revenue
2017-08-10 04:29 GMT+8:00 来源：SA Editor Mohit Manghnani
Portola Pharmaceuticals (NASDAQ:PTLA): Q2 EPS of -$1.22 misses by $0.24.
Revenue of $3.8M (-10.2% Y/Y) misses by $5.04M.
Press Release
$Po...查看全文

二的有理有据2017-08-01 03:51

$Portola制药(PTLA)$ 医药界的tsla，always later than promise查看全文

精灵C2017-07-06 23:05

$Portola制药(PTLA)$ 买了PTLA,受专业热心人士@Stevevai1983的影响，多有受教了！查看全文

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040371  Size: 12 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040380  Size: 16 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040346  Size: 20 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040356  Size: 8 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040364  Size: 13 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040326  Size: 23 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040332  Size: 10 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040341  Size: 25 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040307  Size: 23 KB 网页链接

$Portola制药(PTLA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-040311  Size: 12 KB 网页链接